Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Sharecast News) - All eyes on Wednesday will be on the Chancellor´s budget statement, although according to Barclays Research, Rishi Sunak is unlikely "to alter the contours of the already restrictive policy mix meaningfully".
Read more
UK earnings, trading statements calendar - next 7 days
Read more
(Refiles to remove extraneous word from lead)* UK announces 9.7 bln pounds of green investment* Johnson seeks to harness trillions of the markets* UK to partner with Bill Gates on emerging green techBy William JamesLONDON, Oct 19 (Reuters) - British ...
Read more(Changes date, adds Johnson speech, Bill Gates)By William JamesLONDON, Oct 18 (Reuters) - Britain announced nearly 10 billion pounds ($13.72 billion) of private investment in green projects on Tuesday, as Prime Minister Boris Johnson hosted an inv...
Read moreBy William JamesLONDON, Oct 18 (Reuters) - Britain said it had attracted nearly 10 billion pounds ($13.72 billion) from global investors to fund its green regeneration agenda, as it hosted an investment summit involving 200 of the world's top fina...
Read moreLONDON BROKER RATINGS: UBS lifts Fresnillo; Jefferies says buy Drax
Read more(Sharecast News) - Analysts at Berenberg reduced their target price for shares of GlaxoSmithKline from 1,625.0p to 1,540.0p, but stood by their 'buy' recommendation on the shares, pointing out that the company's exit from its Consumer healthcare division was now closer and arguing that the stock remained "fundamentally undervalued".
Read more* Treatment is first COVID preventative shot other than vaccines* Drug, Evusheld, shown to save lives and prevent severe disease* EMA gives no timeline for possible approval (Adds detail)Oct 14 (Reuters) - Europe's drug regulator said on Thursday ...
Read morePRESS: Private equity firms eye Glaxo's consumer unit - Bloomberg
Read moreLONDON MARKET CLOSE: Stocks fall on weakening global growth outlook
Read moreFRANKFURT, Oct 12 (Reuters) - Curevac said it would not have to pay back the 450 million euros ($520 million) it received from the European Union as part of an advance purchasing agreement of COVID-19 vaccines because the funding was not continge...
Read more* CureVac says 450 mln eur from EU is non-refundable* Trials showed 47% efficacy for original vaccine* Move means vaccine supply deal with EU ends* CureVac shares sink almost 14% (Adds details on EU deal, research focus)By Zuzanna Szymanska and Lud...
Read more* Trials showed 47% efficacy for original vaccine* Move means vaccine supply deal with EU ends* CureVac shares sink almost 14% on news (Adds details)BERLIN, Oct 12 (Reuters) - CureVac will withdraw its first-generation COVID-19 vaccine candidate an...
Read more* Move comes after human trials showed 47% efficacy of vaccine* Shares sink 14% on news* Co pins hopes on next-gen shot it's developing with GSK* Move means supply deal with EU ends (Adds details)BERLIN, Oct 12 (Reuters) - CureVac will withdraw it...
Read more(Sharecast News) - GlaxoSmithKline shares topped the FTSE 100 index on Tuesday following a report that the pharmaceuticals giant's consumer unit was drawing interest from private equity firms in what could lead to the biggest buyout of all time.
Read more
Last checked at